Share Email Print
cover

Journal of Biomedical Optics • Open Access

Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer
Author(s): Ali A. Maawy; Yukihiko Hiroshima; Yong Zhang; George A. Luiken; Robert M. Hoffman; Michael Bouvet

Paper Abstract

Labeling of metastatic tumors can aid in their staging and resection of cancer. Near infrared (NIR) dyes have been used in the clinic for tumor labeling. However, there can be a nonspecific uptake of dye by the liver, lungs, and lymph nodes, which hinders detection of metastasis. In order to overcome these problems, we have used two NIR dyes (DyLight 650 and 750) conjugated to a chimeric anti-carcinoembryonic antigen antibody to evaluate how polyethylene glycol linkage (PEGylation) can improve specific tumor labeling in a nude mouse model of human pancreatic cancer. The conjugated PEGylated and non-PEGylated DyLight 650 and 750 dyes were injected intravenously into non-tumor-bearing nude mice. Serum samples were collected at various time points in order to determine serum concentrations and elimination kinetics. Conjugated PEGylated dyes had significantly higher serum dye concentrations than non-PEGylated dyes (p=0.005 for the 650 dyes and p<0.001 for the 750 dyes). Human pancreatic tumors subcutaneously implanted into nude mice were labeled with antibody-dye conjugates and serially imaged. Labeling with conjugated PEGylated dyes resulted in significantly brighter tumors compared to the non-PEGylated dyes (p<0.001 for the 650 dyes; p=0.01 for 750 dyes). PEGylation of the NIR dyes also decreased their accumulation in lymph nodes, liver, and lung. These results demonstrate enhanced selective tumor labeling by PEGylation of dyes conjugated to a tumor-specific antibody, suggesting their future clinical use in fluorescence-guided surgery.

Paper Details

Date Published: 2 June 2014
PDF: 7 pages
J. Biomed. Opt. 19(10) 101504 doi: 10.1117/1.JBO.19.10.101504
Published in: Journal of Biomedical Optics Volume 19, Issue 10
Show Author Affiliations
Ali A. Maawy, Univ. of California, San Diego (United States)
Yukihiko Hiroshima, Univ. of California, San Diego (United States)
AntiCancer, Inc. (United States)
Yokohama City Univ. (Japan)
Yong Zhang, AntiCancer, Inc. (United States)
George A. Luiken, OncoFluor, Inc. (United States)
Robert M. Hoffman, Univ. of California, San Diego (United States)
AntiCancer, Inc. (United States)
Michael Bouvet, Univ. of California, San Diego (United States)
VA San Diego Healthcare System (United States)


© SPIE. Terms of Use
Back to Top